Queen's University at Kingston
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1841-10-16
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.queensu.ca
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Phase 3
Not yet recruiting
- Conditions
- Non-small Cell Lung Cancer
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 320
- Registration Number
- NCT06686771
Pilot Feasibility Study of a Pragmatic Mixed-Methods Randomized Controlled Trial on a Follow-Up Bundle of Care for ICU Survivors and Caregivers
Not Applicable
Recruiting
- Conditions
- Critical IllnessDelirium in the Intensive Care Unit
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 40
- Registration Number
- NCT06681649
- Locations
- 🇨🇦
Queen's University, Kingston, Ontario, Canada
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Phase 3
Recruiting
- Conditions
- Advanced Head and Neck Cancer
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 196
- Registration Number
- NCT06641791
- Locations
- 🇨🇦
Odette Cancer Centre, Toronto, Ontario, Canada
Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics
Not yet recruiting
- Conditions
- Carcinoma
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 120
- Registration Number
- NCT06630273
LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
Phase 2
Recruiting
- Conditions
- Melanoma
- Interventions
- Drug: Standard of Care Immune Checkpoint Blockade
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 128
- Registration Number
- NCT06623461
- Locations
- 🇨🇦
London Health Sciences Centre Research Inc., London, Ontario, Canada
🇨🇦Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
🇨🇦CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Phase 3
Recruiting
- Conditions
- Prostate Cancer (Adenocarcinoma)
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 830
- Registration Number
- NCT06592924
- Locations
- 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
A Chinese Version of the Thinking Health Program for East Asian Pregnant Immigrant People in Canada
Not Applicable
Recruiting
- Conditions
- Perinatal Depression
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 50
- Registration Number
- NCT06446089
- Locations
- 🇨🇦
Queen's University, Kingston, Ontario, Canada
Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
Phase 3
Recruiting
- Conditions
- Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 236
- Registration Number
- NCT06439225
- Locations
- 🇨🇦
Waterloo Regional Health Network (WRHN), Kitchener, Ontario, Canada
🇨🇦University Health Network, Toronto, Ontario, Canada
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada
Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living with HIV
Not Applicable
Active, not recruiting
- Conditions
- Cervical Cancer
- Interventions
- Biological: Vaccination ProvisionBiological: Vaccination Provision 2
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 2000
- Registration Number
- NCT06402383
- Locations
- 🇹🇿
Pamoja Tunaweza Women's Centre, Moshi, Tanzania
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
Phase 3
Recruiting
- Conditions
- Cancer Metastatic
- Interventions
- Radiation: Standard Conventional RadiotherapyRadiation: Stereotactic Body Radiotherapy
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 230
- Registration Number
- NCT06391242
- Locations
- 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦London Health Sciences Centre Research Inc., London, Ontario, Canada
🇨🇦Odette Cancer Centre, Toronto, Ontario, Canada